Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|August 31, 2007
Rapamycin: something old, something new, sometimes borrowed and now renewedC M Hartford, M J RatainSeminars in Oncology|August 1, 1992
Therapeutic relevance of pharmacokinetics and pharmacodynamicsM J RatainEuropean Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J RatainCancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacodynamics and long-term toxicity of etoposideK Kobayashi, M J RatainInvestigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J RatainJournal of the National Cancer Institute|February 3, 1993
Model-guided determination of maximum tolerated dose in phase I clinical trials: evidence for increased precisionR Mick, M J RatainEuropean Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Pharmacogenetics and cancer chemotherapyL Iyer, M J RatainClinical Pharmacology and Therapeutics|August 1, 1994
Bootstrap validation of pharmacodynamic models defined via stepwise linear regressionR Mick, M J RatainCancer Chemotherapy and Pharmacology|January 1, 1993
Statistical approaches to pharmacodynamic modeling: motivations, methods, and misperceptionsR Mick, M J RatainSeminars in Oncology|December 1, 1992
New perspectives on the toxicity of etoposideK Kobayashi, M J RatainPageof 19